Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Medtech Matters

Medtech Matters artwork

An Early Look at FDA’s Guidance Focus for 2027, Part 2

Nov 2, 20261 hr 2 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re continuing the conversation of guidance documents that are expected to gain the attention of the agency in 2027. While some of the guidance topics outlined may not see an official release for a few years, several will come into effect in the next year. Are these the highest priority areas that require guidance? Has FDA missed out by not including certain focus areas? During this conversation, the following questions are addressed: Can you provide a quick review of part 1 of this discussion? What can we expect with regard to guidance in 2027 from FDA? What’s on FDA’s A-List of Guidance Topics for 2027? What’s on the B-List of Guidance Topics for 2027? What’s on the “Under Construction List” of Guidance Topics for 2027? How do topics get on these lists? What topics are NOT on these lists but probably should be? Do you have suggestions for FDA regarding guidance documents? Should FDA even be in the business of writing guidance documents? Is that really their job? What else is important? What are the takeaways? Listen to this discussion and see what you think of the upcoming FDA guidance. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, plea Send us Fan Mail For more medtech news and information, visit https://www.mpomag.com.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. An Early Look at FDA’s Guidance Focus for 2027, Part 1

    Nov 2, 202647 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we review the list of guidances FDA expects to begin to focus on in 2027. The list really represents the...

    Credit the people on this episode

  2. A Preview of MDUFA VI: Changes and Highlights, Part 2

    Sep 11, 202650 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re into part 2 of the discussion in an early look at the next Medical Device User Fee Act, MDUFA VI, which...

    Credit the people on this episode

  3. A Preview of MDUFA VI: Changes and Highlights, Part 1

    Sep 11, 202648 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re taking an early look at the next version of the Medical Device User Fee Act, MDUFA VI, which would go...

    Credit the people on this episode

  4. The Value in Partnering for Sterility Testing

    Sep 9, 202626 minAudio

    In this Medtech Matters podcast episode, sponsored by Nelson Labs, two representatives from the company offer their expertise and insights on sterility testing. Amina Rahmoune, Laboratory Operations Manager - Sterility...

    Credit the people on this episode

  5. ECRI's 2026 Top 10 Health Technology Hazards

    Jul 30, 202656 minAudio

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re reviewing the list of top health technology hazards identified by ECRI. ECRI is an independent, nonprofit...

    Credit the people on this episode